The American electorate stunned the world this week, voting Donald Trump to be the 45th US President. Following Trump’s unexpected victory, biopharma stocks rallied while the scientific community expressed concern over the potential effects of a Trump administration on research and development. Forty-two percent of 158 respondents to a The Scientist Twitter poll indicated that they believed research funding would be most impacted by the incoming administration. “I am taking a breath and trying to explain to my children that science matters, that global climate change is indeed occurring and we are watching it happen via species migration, storm intensity, and inundation on our coastlines,” wrote Deanne Caffee-Cooper on The Scientist’s Facebook page.
Neanderthal DNA may have helped modern humans adapt to diverse environments, according to a genomic analysis published in Current Biology this week (November 10). A team led by researchers at the University of Washington compared the genomes ...
